MedPath

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

Conditions
Pancreatic Space Occupying
Registration Number
NCT04986215
Lead Sponsor
Changhai Hospital
Brief Summary

To clarify the value of genomic testing in the clinical diagnosis or prognosis of pancreatic space occupation, provide a basis for the selection of clinical diagnosis methods for pancreatic space occupation, optimize clinical management strategies, and improve the prognosis of patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Age 18-85, no gender limit
  2. Imaging examinations suggest that the clear pancreas has clear space-occupying lesions
  3. Admitted to our department, ready to undergo endoscopic ultrasound biopsy to confirm the diagnosis
Exclusion Criteria
  1. There are contraindications for endoscopic ultrasound biopsy
  2. Failed to join the group or refused follow-up due to various reasons

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differential lncRNA detected by sequencingJune 2023

The diagnosis of lncRNA in pancreatic space occupying

Differential mRNA detected by sequencingJune 2023

The diagnosis of mRNA in pancreatic space occupying

Differential microRNA detected by sequencingJune 2023

The diagnosis of microRNA in pancreatic space occupying

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath